Zhitong Finance App News, Ruike Bio-B (02179) announced that at the annual shareholders' meeting, Dr. Liu Yong, Mr. Li Bu, Ms. Chen Qingqing and Dr. Hong Kunxue were appointed as executive directors of the 2nd board of directors; Dr. Wang Ruwei, Dr. Zhang Jiaxin, Dr. Zhou Hongbin and Mr. Hu Houwei were appointed as non-executive directors of the 2nd board of directors; and Dr. Xia Lijun, Mr. Liang Guodong, Professor GAO Feng and Professor Yuan Hui Ming were appointed as independent non-executive directors of the 2nd board of directors.

Following the formation of the second board of directors of the company, Dr. Chen Jianping, executive director of the first board of directors of the company, will no longer hold the position of executive director of the company from May 8, 2024 due to the expiration of his term of office.

At the annual shareholders' meeting, Ms. Qian Ranting and Mr. Wang Feizhou were appointed as non-employee representative supervisors of the 2nd Board of Supervisors of the Company.

The board of directors held a board meeting on May 8, 2024 to elect Dr. Liu Yong as the chairman of the second board of directors of the company, effective for a term of three years; Professor Yuan ****, Dr. Xia Lijun, Mr. Li Bu, Mr. Liang Guodong, and Professor GAO Feng were members of the 2nd Board Remuneration and Assessment Committee, and Professor Yuan **** was the chairman; Dr. Xia Lijun, Professor Yuan ****, and Dr. Zhou Hongbin were members of the 2nd Board Audit Committee; and Dr. Liu Yong, Dr. Xia Lijun, and Mr. Liang Guodong, GAO The professor is a member of the 2nd Board of Directors Nomination Committee, and Dr. Liu Yong is the chairman. The term of office of the members of the Board of Directors Special Committee mentioned above is the same as the term of office of their directors, and takes effect from the date of review and approval by the board

The board of supervisors held a board of supervisors meeting on May 8, 2024, and Ms. Qiao Weiwei was appointed as the chairman of the second board of supervisors of the company.

Since Dr. Liu Yong's term as the company's general manager will expire in May 2024, the board of directors renewed Dr. Liu Yong as the company's general manager at the board meeting held on May 8, 2024, effective from the date of review and approval by the board of directors, for a term of three years.